with Real Questions
Part 1 Latest
and2025_2026
Detailed Answers.pdf
Antibiotics
with Real Questions
Part 1 Latest
and2025_2026
Detailed Answers.pdf
with Real Questions and Detailed Answers.pdf
Antibiotics Part 1 Latest 2025/2026 with
Real Questions and Detailed Answers
Guidehttps://www.stuvia.com/dashboard!@_)#*)(@$)($@*($@)($@*_
Antibiotics Part 1 Latest 2025_2026 Antibiotics
with Real Questions
Part 1 Latest
and2025_2026
Detailed Answers.pdf
Antibiotics
with Real Questions
Part 1 Latest
and2025_2026
Detailed Answers.pdf
with Real Questions and Detailed Answers.pdf
,Antibiotics pt 1.pdf Antibiotics pt 1.pdf Antibiotics pt 1.pdf
Terms in this set (51)
•what condition are we treating? Antimicrobial Therapy Considerations
•which pathogen commonly causes the infection?
•which antibiotic (s) is active against those
pathogens?
•what are the local resistance patterns?
•will the drug reach site of infection?
•route of administration
•patient factors
•monitoring parameters
•duration of therapy
•cost
drug, pathogen, patient What are the three big components to consider for antimicrobial therapy?
prophylactic, empiric, definitive What are the three antimicrobial therapy categories
Antibiotics pt 1.pdf Antibiotics pt 1.pdf Antibiotics pt 1.pdf
,Antibiotics pt 1.pdf Antibiotics pt 1.pdf Antibiotics pt 1.pdf
cancer patients Prophylactic
immunocompromised patients
surgical patients Prevent an infection that has not yet developed
Should be limited to patients at high risk of developing an infection: (3 types
of patients)
ex: cefazolin before surgery to prevent Staph infection of the surgical site
Antibiotics pt 1.pdf Antibiotics pt 1.pdf Antibiotics pt 1.pdf
, Antibiotics pt 1.pdf Antibiotics pt 1.pdf Antibiotics pt 1.pdf
Empiric Antimicrobial Therapy Categories
__: Proven or suspected infection but responsible pathogen has not yet
been identified - therapy initiated based on educated guess, knowing usual
suspects
Note: samples for Gram staining, C&S collected prior to initiating therapy
eg: vancomycin, tobramycin and meropenem to treat an ICU patient with
suspected VAP
definitive Antimicrobial Therapy Categories
__: Pathogen is known
C&S results are known
'de-escalate' empiric therapy
•narrowing spectrum
eg: switching from vancomycin, ciprofloxacin and meropenem to linezolid
for a patient with HAP caused by MRSA
Antibiotics pt 1.pdf Antibiotics pt 1.pdf Antibiotics pt 1.pdf